This site is intended for healthcare professionals
  • Home
  • /
  • Guidelines
  • /
  • Contraceptive and procreative management
  • /
  • Long-acting reversible contraception

Long-acting reversible contraception

Read time: 1 mins
Last updated:1st Jul 2019
Long-acting reversible contraception - National Institute for Health and Care Excellence (NICE)

This guideline covers long-acting reversible contraception. It aims to increase the use of long-action reversible contraception by improving the information given to women about their contraceptive choices.

- The Royal College of Obstetricians and Gynaecologists has produced guidance for gynaecological services during the COVID-19 pandemic.

In March 2019 we revised our decision on how to implement the recommendations of our October 2017 review. Although no new evidence was identified, we noted significant changes in how we commission and provide contraceptive services in England. We have removed the recommendations in this guideline that no longer fit with current practice. There are also many new LARC products now available. See NICE’s implementation resource summary for long-acting reversible contraception for links to the latest information.

Read full guideline